Escobedo BL, González MRJ, Berrones MD, De la Cajiga LA, Iglesias LJ, Bernárdez ZI

Language: Spanish
References: 11
Page: 345-349
PDF size: 147.38 Kb.

ABSTRACT

Retinopathy of prematurity is a peripheral proliferative vitreoretinopathy that occurs in preterm infants, multifactorial etiology, with immaturity being its main risk factor. In Mexico, the incidence has a wide variation and reaches up to 45.8% in children under 32 weeks of gestation or 1,500 g. The main objective is to demonstrate that the incidence of retinopathy of prematurity is lower than the literature, to look for a relationship between the risk factors. It is an observational, descriptive, longitudinal, prospective cohort study, newborns under 32 weeks or less than 1,750 grams at birth, reviewed by the ophthalmology service. We found an average of gestational age 30 ± 2.39 weeks, average weight of 1,382 ± 331.1 grams, 12.8% retinopathy, 51.4% male, 100% sepsis, preeclampsia was the predominant maternal pathology. Significance was observed: gestational age 0.152 (0.048-0.485) p = 0.001, birth weight 1.008 (1.001-1.0014) p = 0.016, intraventricular hemorrhage 11.325 (1.483-86.469) p = 0.019, enterocolitis IIA 2.75 (1.031-7.339) p = 0.043, bronchopulmonary dysplasia 11.370 (3.517-36.738) p = 0.009 .In conclusion, there is a low incidence of retinopathy of prematurity, screening is excellent, emphasis should be placed on the surveillance of proinflammatory and hypertensive states of pregnancy and never exceed the administration of oxygen.

REFERENCES

1. Bancalari MA, González RR, Vásquez CC, Pradenas KL. Retinopatía del prematuro: incidencia y factores asociados. Rev Chil Pediatr. 2000; 71 (2): 114-121.

2. González-Urquidi O, Fuente-Torres MA. Incidencia de retinopatía del prematuro en el Hospital Dr. Manuel Gea González. Rev Mex Oftalmol. 2004; 78 (1): 1-4.

3. Zin A, Fuente TM, Gilbert C, Quinn G, Sola A. Guías Oftalmológicas y Neonatales para el Examen, Detección y Tratamiento de Retinopatía del Prematuro en países de Latinoamérica. Agencia Internacional para Prevención de Ceguera Allergan. 2015; (1): 1-32.

4. Austeng D, Källen KB, Ewald UW, Jakobsson PG, Holmström GE. Incidence of retinopathy of prematurity in infants born before 27 weeks’ gestation in Sweden. Arch Ophthalmol. 2009; 127 (10): 1315-1319.

5. Zin A, Gole GA. Retinopathy of prematurity-incidence today. Clin Perinatol. 2013; 40 (2): 185-200.

6. Detección, diagnóstico y tratamiento de retinopatía del prematuro en el segundo y tercer nivel de atención. México: Secretaría de Salud; 2 de julio de 2015.

7. Twomey PJ. Oxford Handbook of Medical Statistics: Oxford Medical Handbooks. Annals of Clinical Biochemistry. 2011; 49 (3): 308.

8. Carrion JZ, Fortes Filho JB, Tartarella MB, Zin A, Jornada ID Jr. Prevalence of retinopathy of prematurity in Latin America. Clin Ophthalmol. 2011; 5: 1687-1695.

9. Rohsiswatmo R. Retinopathy of prematurity: prevalence and risk factors. Paediatr Indones. 2016; 45 (6): 270.

10. Stokowski L. Revised ROP screening guidelines issued. Adv Neonat Care. 2006; 6 (4): 172.

11. Ortega-Molina JM, Anaya-Alaminos R, Uberos-Fernández J, Solans-Pérez de Larraya A, Chaves-Samaniego MJ, Salgado-Miranda A et al. Genetic and environmental influences on retinopathy of prematurity. Mediators Inflamm. 2015; 2015: 764159.